Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON48664
NL-OMON48664
Completed
Not Applicable

Superior capsular reconstruction of irreparable degenerative rotator cuff tears of the shoulder: a multi-center,comparative, prospective, observational follow-up study - Superior capsular reconstruction of rotator cuff tears

Viecuri Medisch Centrum voor Noord-Limburg0 sites17 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Viecuri Medisch Centrum voor Noord-Limburg
Enrollment
17
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial ended prematurely

Registry
who.int
Start Date
TBD
End Date
May 5, 2021
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Viecuri Medisch Centrum voor Noord-Limburg

Eligibility Criteria

Inclusion Criteria

  • •Age \> 40 years;
  • •Patiënts with a clinical suspicion of a rotator cuff tear scheduled for
  • •arthroscopic superior capsular reconstruction;
  • •Patients have signed informed consent.

Exclusion Criteria

  • •Patients with rheumatoid arthritis
  • •The inability to understand Dutch language
  • •Patients with neurologic impairment influencing functioning affected limb

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Deltoid volume and strength following reverse shoulder arthroplastyglenohumeral arthritisshoulder osteoarthritis1002321310005944
NL-OMON48441HagaZiekenhuis102
Completed
Not Applicable
Safety and Performance Evaluation of the AccuCinch Ventricular Repair System for the treatment of heart failure, with or without functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathydilation of heart left ventriclefunctional mitral regurgitationHeart failure10019280
NL-OMON48568Ancora Heart, Inc.28
Completed
Phase 2
A Phase 1-2, Open-Label, Dose-Finding, Proof of Concept, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors
NL-OMON48575CytomX Therapeutics, Inc.22
Completed
Phase 3
A Phase 1b/3, Multicenter, Trial of Talimogene Laherparepvec in Combination With Pembrolizumab (MK-3475) for Treatment of Unresectable, Stage IIIB to IVM1c Melanoma (MASTERKEY-265)1) Unresectable stage IIIB to IVM1c melanoma2) Unremoved melanoma (type of skin cancer)10040900
NL-OMON50729Amgen15
Completed
Phase 3
A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19corona virusCOVID-19SARS-CoV-2100276651004743810024970
NL-OMON51772Erasmus MC, Universitair Medisch Centrum Rotterdam100